BioLife Solutions
BLFS
15 hedge funds and large institutions have $1.22M invested in BioLife Solutions in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
7% more funds holding
Funds holding: 14 → 15 (+1)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
8% less capital invested
Capital invested by funds: $1.32M → $1.22M (-$102K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$263K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$57K |
| 3 |
AIG
American International Group
New York
|
+$7.15K |
| 4 |
Citigroup
New York
|
+$234 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$129 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$278K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$33.9K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11K |
| 4 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$1K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$24 |
BLFS Hedge Fund Activity: Q3 2014 in Review
15 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2014, worth a combined $1.22M — down 7.7% from $1.32M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BLFS positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Credit Suisse, adding an estimated $263K. The largest seller was Perkins Capital Management, cutting an estimated $278K.
- 15 institutional investors held BioLife Solutions (BLFS) as of Q3 2014, up from 14 in Q2 2014.
- Funds reported $1.22M of BioLife Solutions stock for Q3 2014, down 7.7% quarter-over-quarter.
- 3 funds opened new BioLife Solutions positions in Q3 2014 and 2 closed out, a net change of +1 holder.
- The largest BioLife Solutions buyer in Q3 2014 was Credit Suisse, an estimated $263K added.
- The largest BioLife Solutions seller in Q3 2014 was Perkins Capital Management, an estimated $278K sold.
Based on aggregated 13F filings for Q3 2014.